Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
ROSSARI

Rossari Biotech Share Price

 

 

Rossari Biotech live price: ₹512.6. It opened at ₹515 vs previous close ₹513; intraday high/low: ₹518/₹507. The 50 & 200 DMA stand at ₹475.52/₹567.22.

Rossari Biotech Performance

  • Today's Low
  • ₹507
  • Today's High
  • ₹518
  • 52 Week Low
  • ₹375
  • 52 Week High
  • ₹766
  • Open Price₹515
  • Previous Close₹513
  • Volume121,929
  • 50 DMA₹475.52
  • 100 DMA₹512.54
  • 200 DMA₹567.22

Rossari Biotech Chart

Investment Returns

  • Over 1 Month + 24.61%
  • Over 3 Month -3.49%
  • Over 6 Month -20.82%
  • Over 1 Year -25.7%

Smart Investing Starts Here Start SIP with Rossari Biotech for Steady Growth!

Invest Now

Rossari Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 20.6
  • PEG Ratio
  • 17.3
  • Market Cap Cr
  • 2,839
  • P/B Ratio
  • 2.2
  • Average True Range
  • 21.43
  • EPS
  • 24.86
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 0.07
  • RSI
  • 66.09
  • MFI
  • 87.96

Rossari Biotech Financials

Rossari Biotech Technicals

EMA & SMA

Current Price
₹512.60
-0.4 (-0.08%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹464.59
  • 50 Day
  • ₹475.52
  • 100 Day
  • ₹512.54
  • 200 Day
  • ₹567.22

Resistance and Support

512.77 Pivot Speed
  • R3 529.48
  • R2 523.97
  • R1 518.28
  • S1 507.08
  • S2 501.57
  • S3 495.88

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Rossari Biotech is a leading specialty chemicals manufacturer in India, offering solutions across home and personal care, performance chemicals, and textile specialty chemicals. With three manufacturing plants, it serves clients in over 25 countries with sustainable chemical solutions.

Rossari Biotech has an operating revenue of Rs. 2,291.07 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 9% is okay, ROE of 11% is good. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 8% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 28 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 44 indicates it belongs to a fair industry group of Diversified Operations and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Rossari Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-04-27 Audited Results & Final Dividend
2026-01-17 Quarterly Results
2025-10-15 Quarterly Results
2025-07-19 Quarterly Results
2025-04-25 Audited Results & Final Dividend
Date Purpose Remarks
2025-06-20 FINAL Rs.0.50 per share(25%)Final Dividend
View Rossari Biotech Dividend History Arrow

Rossari Biotech F&O

Rossari Biotech Shareholding Pattern

68.15%
13.38%
4.01%
2.18%
0%
10.11%
2.17%

Rossari Biotech FAQs

Rossari Biotech share price is ₹512 As on 23 April, 2026 | 07:37

The Market Cap of Rossari Biotech is ₹2839 Cr As on 23 April, 2026 | 07:37

The P/E ratio of Rossari Biotech is 20.6 As on 23 April, 2026 | 07:37

The PB ratio of Rossari Biotech is 2.2 As on 23 April, 2026 | 07:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23